gastroparesis after semaglutide Gastroparesis: when the stomach stops PDF) Comparing the risk of

All BioSynth Peptides products are intended for laboratory research purposes only

The recommended schedule from clinical trials is: Weeks 1-4: 2.5 mg once weekly Weeks 5-8: 5 mg once weekly Weeks 9-12: 7.5 mg once weekly Weeks 13-16: 10 mg once weekly Weeks 17-20: 12.5 mg once weekly Week 21+: 15 mg once weekly (maximum dose) Not everyone follows this exact schedule

If more than 4 days or 96 hours have passed since the missed dose, skip the dose and take the next dose on a regularly scheduled day

Most cases were mild to moderate and did not lead to discontinuation

Tirzepatide has shown promising results in promoting significant weight reduction, improving blood sugar control, and lowering the risk of heart-related issues, making it an effective solution for those seeking to improve their overall health and well-being